263 related articles for article (PubMed ID: 11012773)
1. CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.
Gagro A; McCloskey N; Challa A; Holder M; Grafton G; Pound JD; Gordon J
Immunology; 2000 Oct; 101(2):201-9. PubMed ID: 11012773
[TBL] [Abstract][Full Text] [Related]
2. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
[TBL] [Abstract][Full Text] [Related]
4. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.
Wortis HH; Teutsch M; Higer M; Zheng J; Parker DC
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3348-52. PubMed ID: 7536930
[TBL] [Abstract][Full Text] [Related]
5. IL-2 expands and maintains IgM plasmablasts from a CD5+ subset contained within the germinal centre cell-enriched (surface IgD-/CD39- buoyant) fraction of human tonsil.
Holder MJ; Abbot SD; Milner AE; Gregory CD; Casamayor M; Johnson GD; MacLennan IC; Gordon J
Int Immunol; 1993 Sep; 5(9):1059-66. PubMed ID: 7694641
[TBL] [Abstract][Full Text] [Related]
6. Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes.
Haas KM; Estes DM
Immunology; 2000 Feb; 99(2):272-8. PubMed ID: 10692047
[TBL] [Abstract][Full Text] [Related]
7. Effect of B-cell receptor engagement on CD40-stimulated B cells.
Schilizzi BM; Boonstra R; The TH; de Leij LF
Immunology; 1997 Nov; 92(3):346-53. PubMed ID: 9486107
[TBL] [Abstract][Full Text] [Related]
8. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.
Cong YZ; Rabin E; Wortis HH
Int Immunol; 1991 May; 3(5):467-76. PubMed ID: 1716972
[TBL] [Abstract][Full Text] [Related]
9. The antigen receptor complex on cord B lymphocytes.
Macardle PJ; Weedon H; Fusco M; Nobbs S; Ridings J; Flego L; Roberton DM; Zola H
Immunology; 1997 Mar; 90(3):376-82. PubMed ID: 9155644
[TBL] [Abstract][Full Text] [Related]
10. Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
Morikawa K; Torii I; Morikawa S
Scand J Immunol; 2002 Jan; 55(1):44-52. PubMed ID: 11841691
[TBL] [Abstract][Full Text] [Related]
11. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
[TBL] [Abstract][Full Text] [Related]
12. The identification and characterization of a ligand for bovine CD5.
Haas KM; Estes DM
J Immunol; 2001 Mar; 166(5):3158-66. PubMed ID: 11207268
[TBL] [Abstract][Full Text] [Related]
13. Co-ligation of surface IgM and CD40 on naive B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype.
Wheeler K; Gordon J
Int Immunol; 1996 Jun; 8(6):815-28. PubMed ID: 8671671
[TBL] [Abstract][Full Text] [Related]
14. Does CD40 ligation induce B cell negative selection?
Martínez-Barnetche J; Madrid-Marina V; Flavell RA; Moreno J
J Immunol; 2002 Feb; 168(3):1042-9. PubMed ID: 11801637
[TBL] [Abstract][Full Text] [Related]
15. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.
Yanaba K; Bouaziz JD; Matsushita T; Tsubata T; Tedder TF
J Immunol; 2009 Jun; 182(12):7459-72. PubMed ID: 19494269
[TBL] [Abstract][Full Text] [Related]
16. Growth factor requirements for the stimulation of germinal center B cells: evidence for an IL-2-dependent pathway of development.
Holder MJ; Liu YJ; Defrance T; Flores-Romo L; MacLennan IC; Gordon J
Int Immunol; 1991 Dec; 3(12):1243-51. PubMed ID: 1723294
[TBL] [Abstract][Full Text] [Related]
17. Locomotor properties of human germinal centre B cells: activation by anti-CD40 and IL-4 allows chemoattraction by anti-immunoglobulin.
Komai-Koma M; Wilkinson PC
Immunology; 1997 Jan; 90(1):23-9. PubMed ID: 9038708
[TBL] [Abstract][Full Text] [Related]
18. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages.
Rabin E; Cong YZ; Wortis HH
Ann N Y Acad Sci; 1992 May; 651():130-42. PubMed ID: 1376028
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of immunoglobulin E synthesis through Fc gammaRII (CD32) by a mechanism independent of B-cell receptor co-cross-linking.
Horejs-Hoeck J; Hren A; Mudde GC; Woisetschläger M
Immunology; 2005 Jul; 115(3):407-15. PubMed ID: 15946258
[TBL] [Abstract][Full Text] [Related]
20. CD40 signalling in ileal Peyer's patch B cells: implications for T cell-dependent antigen selection.
Griebel P; Ferrari G
Int Immunol; 1995 Mar; 7(3):369-79. PubMed ID: 7540860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
